March is the month in which some application deadlines for funding programs end. Therefore, it would be advisable to quickly check the application deadlines.
The International Foundation for Ethical Research (IFER) is now accepting pre-proposal applications for the 2027 Graduate Fellowship program. IFER Graduate Fellowships support projects that advance the development, validation, or implementation of human-relevant, non-animal methodologies in research, testing, or education.
A European research team from Belgium, France and Italy has successfully used an in vitro model to answer the question of whether testicular tissue from transgender women is suitable for producing human testicular organoids.
A Science article reports on the current evaluation standards for AI programs based on neural networks (large language models, LLM) in order to enable independent scientific work in the future.
Using cells from Parkinson's patients, a Munich and Göttingen research team led by Prof. Lena Burbulla from Ludwig Maximilian University in Munich has discovered that ATP deficiency disrupts the storage process of cytosolic dopamine in synaptic vesicles. The study revealed an ATP-sensitive mechanism that regulates dopamine homeostasis via VMAT2 and vesicle dynamics in dopaminergic neurons of the midbrain.
Using a two-organ disease model on a microchip, a German-Canadian research team involving research institutions from Vancouver, Berlin, and Münster has characterized the suitability of a low-molecular TSLP inhibitor to treat atopic diseases.
For years, Mainz University Medical Center has been committed to promoting animal-free methods and only allowing research that complies with animal welfare standards. For this reason, an annual young scientist award for animal welfare in the field of 3R has been established in 2021. The application deadline for this year is March 23, 2026.
A recent feature in the journal Drug Discovery Today discussed new animal-free approaches (NAMs) to research treatment options for drug-resistant epileptic seizures.
A panel of experts from the Japanese Ministry of Health has approved two products made from iPS cells under certain conditions, paving the way for the world's first practical application of products made from iPS cells. The responsible ministry still has to authorize the process.
At the Braunschweig Center for Systems Biology (BRICS), novel mini-laboratories are being developed on a chip that combine electrical, optical, and microfluidic technologies. This allows researchers to observe, stimulate, and analyze nerve cells under realistic conditions without animal testing.